PFS Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Buy |
1,160
+50
| +5% | +$9.28K | 0.11% | 64 |
|
|
2025
Q1 | $233K | Buy |
1,110
+2
| +0.2% | +$419 | 0.12% | 58 |
|
|
2024
Q4 | $197K | Buy |
1,108
+3
| +0.3% | +$533 | 0.11% | 68 |
|
|
2024
Q3 | $218K | Sell |
1,105
-115
| -9% | -$22.7K | 0.12% | 55 |
|
|
2024
Q2 | $209K | Buy |
1,220
+3
| +0.2% | +$515 | 0.13% | 58 |
|
|
2024
Q1 | $222K | Buy |
1,217
+103
| +9% | +$18.8K | 0.15% | 53 |
|
|
2023
Q4 | $173K | Buy |
1,114
+145
| +15% | +$22.5K | 0.12% | 60 |
|
|
2023
Q3 | $144K | Buy |
969
+4
| +0.4% | +$596 | 0.13% | 54 |
|
|
2023
Q2 | $130K | Buy |
965
+253
| +36% | +$34.1K | 0.11% | 58 |
|
|
2023
Q1 | $113K | Sell |
712
-28
| -4% | -$4.46K | 0.11% | 58 |
|
|
2022
Q4 | $120K | Buy |
740
+2
| +0.3% | +$323 | 0.13% | 53 |
|
|
2022
Q3 | $99.1K | Buy |
738
+2
| +0.3% | +$268 | 0.11% | 55 |
|
|
2022
Q2 | $113K | Sell |
736
-14
| -2% | -$2.15K | 0.11% | 54 |
|
|
2022
Q1 | $122K | Sell |
750
-35
| -4% | -$5.67K | 0.11% | 57 |
|
|
2021
Q4 | $106K | Buy |
+785
| New | +$106K | 0.08% | 69 |
|